Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?
Nathan W.D. Lamond, Chris Skedgel, Tallal Younis
科研成果: 期刊稿件 › 文献综述 › 同行评审
14
引用
（Scopus）